93419 ⎘
Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups; Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
#2COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
#3Compounds and compositions for intracellular delivery of therapeutic agents
#4APPLICATIONS OF AMIDE ANALOGS OF TRITERPENES IN CURES OF CANCER AND OTHER DISEASES
#5NOVEL HEADGROUP LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
#6Compounds and compositions for intracellular delivery of therapeutic agents
#7COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
#8Decarboxylase inhibitors for treating Parkinson's disease
#9QUATERNARY AMMONIUM SALTS AS INHIBITORS OF TRIMETHYLAMINE PRODUCTION
#10IONIZABLE AMINE LIPIDS
#11Amide compounds, pharmaceutical compositions thereof, and methods of using the same
#12Compounds and methods for inducing chondrogenesis
#13Method for preparing 2-hydroxyl-4-(2, 3-disubstituted benzyloxy)-5-substituted benzaldehyde derivative
#14Compounds and compositions for intracellular delivery of therapeutic agents
#15Nicotinyl alcohol ether derivative, preparation method therefor, and pharmaceutical composition and uses thereof
#16Benzyl phenyl ether derivative, preparation method therefor, and pharmaceutical composition and uses thereof
#17Phenylate derivative, preparation method therefor, and pharmaceutical composition and uses thereof
#18Compounds and compositions for intracellular delivery of therapeutic agents
#19Preparation of sulfonamide-containing antimicrobials and substrate treating compositions of sulfonamide-containing antimicrobials
#20Polyamine sulfonamides and uses thereof
#21Process for hydrogenating ketones in the presence of Ru(II) catalysts
#22Compounds and compositions for intracellular delivery of therapeutic agents
#23Use of dual-cation fluorocarbon surfactant as amphiphobic wettability reversal agent in drilling fluid
#24Compounds and compositions for intracellular delivery of therapeutic agents
#25Heat-sensitive recording material
#26Hydrophilic oil repellent and production method of same, surface coating material, coating film, resin composition, oil-water separation filter material, and porous body
#27Compounds and compositions for intracellular delivery of therapeutic agents
#28Compounds and compositions for intracellular delivery of therapeutic agents
#29PROCESS FOR HYDROGENATING KETONES IN THE PRESENCE OF RU(II) CATALYSTS
#30IDO inhibitors
#31Compounds useful as immunomodulators
#32Compounds and methods for inducing chondrogenesis
#33Synthesis of Tetracyclines and intermediates thereto
#34NOVEL PHENICOL ANTIBACTERIALS
#35Phenicol antibacterials
#36Cannabinoid receptor 2 (CB2) inverse agonists and therapeutic potential for multiple myeloma and osteoporosis bone diseases
#37Compounds and methods for inducing chondrogenesis
#38Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
#39Method for producing diamine compound
#40Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
#41Process to produce fluorinated betaines
#42Methods for treating siliciclastic hydrocarbon-bearing formations with fluorinated amine oxides
#43Benzyl sulfonamide derivatives useful as MOGAT-2 inhibitors
#44Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
#45Cannabinoid receptor 2 (CB2) inverse agonists and therapeutic potential for multiple myeloma and osteoporosis bone diseases
#46Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
#47Glycine compound
#48Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
#49Process for hydrogenating ketones in the presence of Ru(II) catalysts
#50Synthesis of tetracyclines and intermediates thereto
#51Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
#52Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
#53CERTAIN KYNURENINE-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF
#54HIV-1 Protease Inhibitors
#55Inhibitors for the soluble epoxide hydrolase
#56Cyclic hydrocarbon compounds for the treatment of diseases
#57SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES
#58Amine derivatives having NPY Y5 receptor antagonistic activity and the uses thereof
#59Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
#60Amine derivative having NPY Y5 receptor antagonistic activity
#61ACETYL 2-HYDROXY-1,3-DIAMINOALKANES
#62Polyamine derivatives
#63Amine derivative having NPY Y5 receptor antagonistic activity
#64Inhibitors for the soluble epoxide hydrolase
#65PESTICIDALLY ACTIVE KETONE AND OXIME DERIVATIVES
#66Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
#67Diaryl Ureas as CB1 Antagonists
#68α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
#691-amino linked compounds
#70Pesticidally active ketone and oxime derivatives
#71Naphthalene compounds
#72Acetyl 2-hydroxy-1, 3-diaminoalkanes
#73Polycationic sulfonamides and use thereof
#74Diamino alcohols and their use as renin inhibitor
#75Amino alcohol derivatives and their activity as renin inhibitors
#76Amide inhibitors of leukotriene A4 hydrolase
#77α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
#78Serine Protease Inhibitors
#79α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
#80Inhibitors for the soluble epoxide hydrolase
#81Compounds for the treatment of Alzheimer's disease
#82Chemical compounds
#83Pesticidally active ketone and oxime derivatives
#84Sulphonamide derivatives
#85Sulfur-containing secondary para-phenylenediamines dye compositions comprising such para-phenylenediamines, processes, and uses thereof
#862-amino- and 2-thio- substituted 1,3-diaminopropanes
#87α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
#88Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
#89Novel anticancer compounds
#90Serine protease inhibitors
#91Inhibitors for the soluble epoxide hydrolase
#92Inhibitors for the soluble epoxide hydrolase
#933,4-disubstituted benzamidines and benzylamines, and analogues thereof, useful as serine protease inhibitors
#94Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
#95Sulfonamide corrosion inhibitors